













  1 
Identification of novel biomarkers of Abdominal Aortic 
Aneurysms (AAA) by 2D-DIGE and MALDI-MS from AAA-
thrombus conditioned media 
Martinez-Pinna R1, Lopez JA2, Ramos-Mozo P1, Blanco-Colio LM1, Camafeita E2, 
Calvo E2, Meilhac O3, Michel JB3, Egido J1, Martin-Ventura JL1,* 
(1) Vascular Research Lab IIS-Fundación Jiménez Díaz-Universidad Autónoma de 
Madrid, Madrid, Spain 
(2) Unidad de Proteómica, Centro Nacional de Investigaciones Cardiovasculares (CNIC), 
Madrid, Spain 
(3) INSERM, U698, Univ Paris Diderot, Sorbonne Paris Cité, AP-HP, Hôpital Bichat, 
Paris, F-75018, France  
* Corresponding Author: 
 Roxana Martinez-Pinna or Jose Luis Martin-Ventura 
 Vascular Research Lab-Fundación Jiménez Díaz-Universidad Autónoma de Madrid 
 Av. Reyes Catolicos, 2 
 28040 Madrid (Spain) 
 e-mail:  jlmartin@fjd.es 
  rmartinezpinna@fjd.es 
 
Running Head: Analysis of vascular tissue conditioned media by 2D-DIGE/MS 
Key words: Differential proteomics, 2D-DIGE, biomarkers, conditioned media, Abdominal 
Aortic Aneurysms  
  2 
Abstract 
In the search for novel biomarkers, non-candidate based-proteomic strategies open-up new 
opportunities to gain a deeper insight into disease processes regarding their molecular 
mechanisms, the risk factors involved and the monitoring of disease progression (1, 2). To 
carry out these complex analyses, the combined use of gel electrophoresis with mass 
spectrometry (MS) represents a powerful choice. In addition, the introduction of protein dye-
labeling has notably improved the reliability of differential expression studies by increasing 
the statistical significance of the protein candidates. Here we describe a strategy where 
different layers (luminal/abluminal) from the intraluminal thrombus (ILT) of human 
abdominal aortic aneurysm (AAA) patients were incubated in protein-free medium. Then, the 
levels of the proteins released were compared by two-dimensional differential in-gel 
electrophoresis (2D-DIGE), and the proteins of interest identified by MS. We consider that 
the use of tissue conditioned media could offer a substantial advantage in the analytical study 
of biological fluids, as they provide a source of proteins to be released to the bloodstream, 
which could serve as potential circulating biomarkers. 
 
1. Introduction 
The scarce correlation between mRNA and protein levels, together with the complexity 
added by alternative splicing mechanisms and post-translational modifications, points out that 
genome alterations alone fail to reflect the whole functional complexity of an organism. In 
this regard, proteomic approaches can provide essential information in different physiological 
scenarios, generally combining electrophoretic or chromatographic separations with mass 
spectrometry for protein identification (3). The past few years have witnessed tremendous 
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advances in the development of proteomic tools, especially those related to MS-based 
approaches. Nevertheless, gel-based strategies continue to offer outstanding capabilities for 
quantitative proteomic studies. Thus, the 2D-DIGE system enables to separate differentially 
dye-labeled proteins in the same gel, therefore minimizing technical variability. The overlay 
of the corresponding images enables an accurate comparison of protein components among 
the samples, which provides a reliable quantitation of differential protein expression. 
The complexity of vascular lesions, as well as that of biological fluids involved (e.g. plasma), 
hinders proteomic approaches. We hypothesized that the blood compartment could reflect 
what was observed in the arterial conditioned medium and thus, that proteins potentially 
released into circulation could serve as disease biomarkers. Our study, performed on the 
thrombus conditioned medium, using 2D-DIGE labeling followed by MS, permitted the 
identification of several proteins associated to key mechanisms involved in AAA 
pathogenesis (4).  
 
2. Materials 
2.1. AAA-tissue conditioned media preparation 
1. Wash buffer: Sterile saline buffer. 
2. Culture medium: RPMI 1640 without fetal bovine serum, containing 1% antibiotics 
and antimycotic (Gibco). 
 
2.2. Sample preparation for 2D-DIGE 
1. 2D clean-up kit for protein precipitation (GE Healthcare). 
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2. Lysis buffer: 30mM Tris-HCl pH 8.5, 7M urea, 2M thiourea, 4% (w/v) CHAPS. 
3. pH indicator paper strips pH 8.0-9.7 (Whatman International Ltd.). 
4. RC-DC protein assay kit (Bio-Rad). 
2.3. Protein labeling for 2D-DIGE 
1. Ten millimolar of L-Lysine monohydro-chloride min 98% (MW 182.6, Sigma). 
2. Ultrapure anhydrous dimethylformamide (DMF) 99.8% (DMF, Sigma). Stable for 3 
months at room temperature. 
3. Five nanomoles of CyDye DIGE Fluor Cy2 minimal dye, 5 nmol CyDye DIGE Fluor 
Cy3 minimal dye and 5 nmol CyDye DIGE Fluor Cy5 minimal dye (GE Healthcare). 
Store at -80°C.  
2.4. Sample preparation and isoelectric focusing (IEF) 
1. Rehydratation buffer for sample loading: 7M urea, 2M thiourea, 4% (w/v) CHAPS, 
0.8% (v/v) IPG Buffer 3-11NL, 50mM DTT and bromophenol blue. 
2. Rehydration buffer for Immobiline DryStrips: 7M urea, 2M thiourea, 4% (w/v) 
CHAPS, 0.8% (v/v) IPG Buffer 3-11NL, 97 mM DeStreak reagent (GE Healthcare) 
and bromophenol blue. 
3. Immobiline DryStrip pH 3–11 NL, 24 cm and Immobiline DryStrip reswelling tray 
(GE Healthcare). 
4. Paper wicks. 
5. PlusOneTM DryStrip Cover Fluid (GE Healthcare). 
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6. IPGphor II IEF system (GE Healthcare).  
2.5. Second dimension 
1. SDS equilibration buffer stock solution: 50 mM Tris-HCl, pH 8.0, 6 M urea, 40% 
(w/v) glycerol and 1% (w/v) SDS. This stock solution must be stored at −20°C.  
2. Reducing Equilibration solution: 1% (w/v) DTT in 10 mL SDS equilibration buffer 
stock solution. Used immediately after preparation.  
3. Alkylating Equilibration solution: 3.5% (w/v) iodoacetamide in10 mL SDS 
equilibration buffer stock solution. Used immediately after preparation. 
4. Ettan DALT six Large Vertical System for 24-cm strips, low-flourescence plates with 
1-mm integral spacers for Ettan DALT, Ettan DALT Cassette Rack and Ettan DALT 
Gel Caster (all from GE Healthcare). 
5. Water-saturated butanol. Use to overlay gels. Store at room temperature. 
6. Two-dimensional DIGE SDS-PAGE (sodium-dodecyl sulphate-polyacrylamide gel 
electrophoresis), 12.5% gel composition (500 mL for 6 gels): 200 mL 30% (w/v) 
acrylamide/bis, 186.5 mL 1M Tris-HCL pH 8.8, and 5 mL 10% SDS; make up to 500 
mL with distilled water. Sonicate complete solution and add 2.5 mL 10% ammonium 
persulphate (APS) and 0.25 mL N,N,N,N′-tetramethyl-ethylenediamine (TEMED) 
before pouring the solution. 
7. SDS electrophoresis running buffer: 25 mM Tris, 192 mM glycine and 0.2% SDS. 
Store at room temperature. 
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2.6. Staining of gels and analysis of gel images 
1. Fixation solution: absolute methanol (12%) and acetic acid (7%). 
2. Silver Staining: PlusOne Silver staining kit, protein (GE Healthcare), containing 
Sensitizing Solution (30% EtOH (v/v), 0.2% Na2S2O3 (w/v), 6.8% CH3COONa 
(w/v)), Silver solution (0.25% AgNO3), Developing Solution (2.5% Na2CO3, 0.015% 
HCOH (v/v) and Stopping Solution (1.46% EDTA (w/v)). 
3. For visualization of CyDye fluorescently labeled proteins, Typhoon 9400 (GE 
Healthcare). 
4. For image analysis, the DeCyder v7.0 (GE Healthcare).  
2.7. Spot digestion 
The following buffers should be freshly prepared, as they degrade very quickly: 
1. Reduction buffer: 10 mM DTT (GE Healthcare) in 50 mM NH4HCO3 (99.5% purity; 
Sigma Chemical). 
2. Alkylation buffer: 55 mM iodoacetamide (Sigma Chemical) in 50 mM NH4HCO3. 
3. Trypsin (Sequencing grade; Promega) at a final concentration of 7.5 ng/l in 50 mM  
NH4HCO3. 
4. 0.2% trifluoroacetic acid (TFA) (99.5% purity, Sigma Chemical) 
5. Pierced V-bottom 96-well polypropylene microplate (Bruker Daltonik).  
6. V-bottom 96-well polypropylene microplates (Greiner Bio-One). 
7. Proteineer DP protein digestion station (Bruker Daltonic).  
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2.8. Sample preparation for MALDI-MS 
1. Matrix solution: 0.2 g/l -cyano-4-hydroxycinnamic acid (Bruker Daltonik) in 50% 
aqueous acetonitrile and 0.2% trifluoroacetic acid. 
2. 600 m AnchorChip prestructured MALDI probe (Bruker Daltonik).  
3. Ultraflex MALDI-TOF/TOF mass spectrometer (Bruker Daltonik) with an automated 
analysis loop controlled by the flexControl 2.2 software (Bruker Daltonik). 
 
3. Methods 
3.1. Patient recruitment and samples 
Recruit thrombus samples from AAA patients who have undergone surgical repair. Written 
consent must be given by the patients.  
3.2. AAA-thrombus conditioned media isolation 
1. Dissect the human AAA thrombus samples under sterile conditions into luminal and 
abluminal parts, respectively at the interface with circulating blood and with the 
remaining media (Figure1) (see Note 1). 
2. Cut luminal and abluminal layers into small pieces (5 mm3) and incubate them 
separately in RPMI 1640 medium containing antibiotics and an antimycotic (Gibco) 
for 24 hours at 37°C (6 mL/g of wet tissue) (see Note 2). 
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3. Centrifuge conditioned media (supernatant containing proteins released by the tissue 
sample) at 3,000 xg for 10 minutes at 20°C to eliminate particulates.  
3.3. Experimental design and DIGE protein labeling 
1. Isolate supernatants from luminal and abluminal layers of ILT human samples from 
SIX individual patients.  
2. Precipitate proteins using the 2D clean-up kit and resuspend them in lysis buffer. 
Make sure that proteins are fully resuspended. Measure protein concentration by RC-
DC protein assay (see Note 3). 
3. Prepare stock CyDye reagents by adding 5µL of dimethyl formamide (DMF) to each 
of three CyDye vials. Spin and store at -80°C until use (see Note 4). 
4. Freshly prepare working CyDye solutions. For 6 gels (12 protein samples), a final       
volume of 6µL per CyDye vial is required. For each CyDye use the following 
volumes: 
a. Volume needed from  stock solution: 6 µL/µmol (CyDye) x 0,4 µmol = 2,4 µL  
b. Volume needed of DMF: 6 µL - 2,4 µL = 3,6 µL 
c. Working solution preparation: 2,4  µL (Stock solution) + 3,6 µL (DMF) = 6µL 
5. Spin-down samples and prepare individual samples with 50 µg of protein extract (see 
Notes 5 and 6). 
6. Label individual samples with Cy3 or Cy5 dyes by adding 1 µL of working solution 
and spin-down. Incubate on ice for 30 minutes in the darkness (see Note 7). 
7. Quench the reaction with 1 µL of 10 mM lysine for 10 minutes in the dark on ice. 
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8. For the internal standard, prepare a pool with 25 µg of protein extract from each 
individual sample. Label with 6 µL of Cy2 dye on ice for 30 minutes in the darkness 
and quench the reaction with 6 µL of 10mM lysine for 10 minutes.  
3.4. Two-dimensional electrophoresis and image acquisition 
1. Rehydrate six 24 cm-long IPG Strips pH3-11non linear (NL) gradient with 450µL 
each of the aforementioned Rehydration buffer containing 97mM DeStreak (GE 
Healthcare) (see Note 8). 
2. Sample preparation for the first dimension: Mix the six-paired samples of Cy3 and 
Cy5-labeled proteins with 50 µg of Cy2-labeled internal standard. Dilute the mixture 
in Rehydration buffer containing 50mM DTT, and resolve them by applying the 
sample mixtures via cup loading to the previously rehydrated IPG Strips (see Note 9). 
3. Isoelectric focusing (IEF): The isoelectric focusing can be carried out on an IPGphor 
II IEF system (GE Healthcare) up to a total of 42 kVh (see Note 10). 
4. IPG strips equilibration: Equilibrate the strips in 10 mL of Reducing SDS 
equilibration buffer during 15 minutes at room temperature with agitation.Then, 
eliminate the Reducing solution and incubate with Alkylating SDS equilibration 
buffer for 15 additional min (see Notes 11 and 12). 
5. Second dimension: SDS-PAGE is carried out on 12% polyacrylamide gels at 2w/gel 
(for overnight running) or after sample entry in the running gel (40 min), increase to 
20w/gel (max. 100w) for in-day gel running (see Notes 13, 14 and 15). 
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6.  Image acquisition: For each gel acquire the Cy2-, Cy3-, and Cy5-labeled channel 
image at excitation/emission wavelength values of 488/520, 523/580, and 633/670 
nm, respectively, using a Typhoon 9400 laser scanner (see Note 16).  
3.5. DIGE image analysis 
Analyse the images using the DeCyder v7.0 software for spot detection and quantification 
and inter-gel matching and statistics:  
1. DIA (Differential In-gel Analysis): This is the DeCyder module for the initial spot 
detection, which compares all three fluorescence images obtained from each gel and 
performs co-detection, background removal and normalization. The outcome is the 
volume of each spot detected in Cy3- and Cy5-labeled samples after normalization 
with respect to the corresponding Cy2 signal measured from the pooled internal 
standard sample. The DIA data sets from each individual gel were collectively 
analyzed using the biological variation analysis (BVA). 
2. BVA (Biological Variation Analysis): This is the second DeCyder module used for 
matching multiple 2D-DIGE gels, which provides statistical analysis of protein 
abundance changes. Consider spots present in all of the 12 images (Cy2-, Cy3-, and 
Cy5-channel images for each gel) with statistical significance at 95% confidence level 
for standardized average spot volume ratios over 1.5.  
3. EDA (Extended Data Analysis): The third DeCyder module for advanced statistical 
analysis generates the final list of candidate spots, Principal Component Analyses 
(PCAs) and their hierarchical clustering, for the characterization and classification of 
biological samples based on protein expression data (see Note 17). 
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3.6. Gel silver staining 
Stain the gels using PlusOne Silver Staining kit from GEHealthcare, with some modifications 
to the manufacturer´s instructions (see Note 18). Briefly:  
1. Incubate gels individually with Fixation solution at least for one hour at 20 ºC for 
protein fixing and gel cleaning (see Note 19). 
2. Incubate gels individually with cold sensitizing solution for 20-30 min (see Note 20). 
3. Wash with distilled water, 3 times 10 min each. 
4. Incubate with 10% silver solution (silver nitrate) for 20 min for silver impregnation. 
5. Wash with distilled water, twice, 1 min each (see Note 21). 
6. Add developing solution containing 0.4% formaldehyde freshly supplemented for 
silver staining. Incubate gels until spots are visible (usually less than 5 min) with 
vigorously shaking. 
7. Incubate gels with stopping solution for at least 15 min to stop silver reduction. 
8. Wash three times, 15 min each, with distilled water, and change the gel container.  
3.7. In-gel tryptic digestion 
Digest samples automatically using a Proteineer DP protein digestion station following the 
protocol of Schevchenko et al. (5) with minor variations: 
1.  Spot picking: Match silver-stained gels against DIGE images and excise selected 
spots manually. Transfer them to pierced V-bottom 96-well microplates loaded with 
ultrapure water. 
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2. Submit gel plugs to reduction with 10 mM DTT (GE Healthcare) in 50 mM 
NH4HCO3 (99.5% purity; Sigma) 
3. Submit to alkylation with 55mM iodoacetamide (Sigma Chemical) in 50mM 
NH4HCO3. 
4. Rinse gel pieces with 50 mM NH4HCO3 and acetonitrile (gradient grade; Merck) and 
dry them under a nitrogen stream.  
5. Protein digestion: Add modified porcine trypsin at a final concentration of 7.5ng/l in 
50mM NH4HCO3 to the dried gel pieces and allow the digestion to proceed at 37 ºC 
for 10h. 
6. Transfer the resulting digestion solutions by centrifugation to V-bottom 96-well 
polypropylene microplates, vacuum-dry them and keep at 4ºC for later MS analysis.  
3.8. MALDI Mass spectrometry 
1. Re-dissolve the dried samples in 10l of matrix solution. 
2. Deposite 0.6l of this solution onto the 600m AnchorChip prestructured MALDI 
probe (6). 
3. Allow the sample-matrix drops to dry at room temperature.  
4. Analyze samples on an Ultraflex MALDI-TOF/TOF mass spectrometer (7) using an 
automated analysis loop controlled by the flexControl 2.2 software.  
5. First step: Acquire MALDI-MS spectra by averaging 400 individual spectra in the 
positive ion reflector mode at 50 Hz laser frequency in the 800 to 3500 m/z range. 
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Perform internal calibration of MALDI-MS mass spectra using the two trypsin 
autolysis ions showing at 842.510 and 2211.105 m/z (see Note 22). 
6. Second step: Acquire MALDI-MS/MS spectra by averaging 800 individual spectra 
from precursor ions showing with intensity > 1500 in the above MALDI-MS spectra. 
7. Perform an automated analysis of mass data using the flexAnalysis 2.2 software to 
obtain peptide (MALDI-MS) and precursor (MALDI-MS/MS) m/z values. 
3.9. MALDI-MS database searching  
1. Combine MALDI-MS and MS/MS data through the BioTools 3.0 program to search a 
nonredundant protein database (NCBInr 20091015, ~ 107 entries, National Center for 
Biotechnology Information, Bethesda US), using the Mascot software v2.2 (Matrix 
Science, London, UK; http://www.matrixscience.com) (8). 
2. Set other relevant search parameters as follows: enzyme, trypsin; fixed modifications, 
carbamidomethyl; allow up to 1 missed cleavage; peptide tolerance ±20 ppm; MS/MS 
tolerance ±0.5 Da. 
3. Consider protein scores significant when greater than 82 (p<0.05). 
 
4. Notes 
1. Tissue samples must be washed with saline buffer before their incubation in the 
culture medium, to minimize blood remains. 
2. Sterile material is required for tissue dissection. 
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3. Supernatants or conditioned media must be precipitated before IEF to remove salts 
and other ionic components that could interfere in both the CyDye labeling reaction, 
and later in the isoelectroforetic separation. To facilitate complete resuspension of 
protein pellets shake vigorously for at least 1h at room temperature. 
4.  After reconstitution, dye reagents (stocks solutions) are stable for three months at -70 
ºC /-80 ºC, while working solutions are stable for just one week at -70 ºC /-80 ºC. 
5. Check that pH of protein extracts is ca. 8.5 to ensure appropriate Fluor dye labeling. 
The pH must be checked on ice after protein precipitation, and when necessary 
carefully modified by addition of small volumes of Tris-HCl (1M; pH9.0) or aqueous 
sodium hydroxide. 
6. Under minimal labeling conditions, 400 pmol Fluor CyDye labels 50 µg of protein.  
7. To ensure adequate and sustained protein labeling not only the labeling reaction must 
be performed on ice and in the dark, but also the labeled samples must be strictly kept 
under these conditions. 
8. It is recommended that the rehydration of IPG strips be completed overnight (or at 
least 10-12 h) at around 20 ºC. The recommended volume must be used to ensure a 
homogeneous strip rehydration and conditioning. 
9. For optimal labeling, the volumes must be adjusted in the 3-5 mg/ml range. 
Furthermore, it is advisable to use comparable loading volumes for all the strips (120 
µL). 
10. IEF conditions recommended for 24cm, pH3-11 IPG strips are as follows: Step 1, 
300V, 3h, gradient; Step 2, 1000V, 5h, gradient; Step 3, 8000V, 2h, gradient; Step 4, 
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8000V, constant up to a total of 42kV h. A final step of 500V is also recommended to 
avoid protein diffusion after focusing. 
11. In the alkylating SDS Equilibration buffer 3.5-4% iodoacetamide (IAA) is 
recommended. During the second equilibration step, IAA must be in excess with 
respect to DTT to guarantee that Cys residues will remain protected by alkylation. 
This excess IAA not only avoids reformation of sulfur–sulfur bonds, but also prevents 
DTT point streaking in gels. 
12. If the second dimension in not run immediately, IPG strips can be stored at -20 ºC for 
a few weeks. Do not store the strips once they have been equilibrated. 
13. Gels must be polymerized overnight at ca. 20 ºC to reduce acrylamide-modified 
artifacts. No stacking gel is necessary as IPG strips works as a stacking gel. 
14. 0.2% SDS-running buffer is recommended instead of the usual 0.1% SDS buffer. 
15. The second dimension can be run at 2w/gel and higher potential values, up to a 
maximum of 17w/gel. Control temperature (e.g., 20 ºC) for optimal protein 
separation. 
16. Gel pre-scanning is advised before acquiring the final image for DeCyder analysis. 
Scanner photomultiplier values must be adjusted in the three channels (Cy2, Cy3 and 
Cy5) to avoid saturation of the spot signals. It is also recommended to use comparable 
maximum values of pixel intensities for the three images. 
17. Results derived from EDA module show data quality, in order to delete outlyers 
values if needed. 
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18. To ensure compatibility with later MS analyses, glutardialdehyde and formaldehyde 
must not be added to sensitizing and silver solutions, respectively. To compensate for 
the slightly decreased sensitivity of the as-prepared silver nitrate solution, the 
developing solution is supplemented with twice the usual concentration of 
formaldehyde. 
19. As a gel fixing solution, methanol is preferred rather that ethanol, as its lower 
reactivity with acetic acid reduces unwanted protein esterification. 
20. The use of a cold sensitizing solution is recommended to minimize gel background. 
21. The gel must be completely submerged into water during the washing steps. Make 
sure that the finals washing steps before the developing process, last strictly one 
minute each to avoid removal of silver ions. 
22. For MALDI-MS/MS, the calibrations must be performed with fragment ion spectra 
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FIGURE LEGENDS 
Figure1. Detailed inspection of an abdominal aortic aneurysm fragment, showing a 
section of the intraluminal thrombus. Abluminal and luminal layers are delimited by 
different cellular composition. Adapted from Fontaine V, Touat Z, Mtairag el M, 
Vranckx R, Louedec L, Houard X, Andreassian B, Sebbag U, Palombi T, Jacob MP, 
Meilhac O, Michel JB. Role of leukocyte elastase in preventing cellular re-
colonization of the mural thrombus. Am J Pathol, 2004, 164:2077–2087  
 
 
 
